Fennec Pharmaceuticals Names Chief Medical, Commercial, and Strategy Officers

MT Newswires Live

2024-10-28

Fennec Pharmaceuticals (FENC) said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.

Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.

Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon Therapeutics (HZNP), Graceway Pharmaceuticals, and Medicis.

Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.

Price: 3.8500, Change: -0.39, Percent Change: -9.20

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2478102976"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2478102976\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2478102976?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-28 20:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2478102976","market":"sh","top_or_hot":-1,"title":"Fennec Pharmaceuticals Names Chief Medical, Commercial, and Strategy Officers","media":"MT Newswires Live","content":"<html><body><p> Fennec Pharmaceuticals (FENC) said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.</p><p>Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.</p><p>Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (HZNP), Graceway Pharmaceuticals, and Medicis.</p><p>Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.</p><p>Price: 3.8500, Change: -0.39, Percent Change: -9.20</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fennec Pharmaceuticals Names Chief Medical, Commercial, and Strategy Officers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFennec Pharmaceuticals Names Chief Medical, Commercial, and Strategy Officers\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2024-10-28 20:20</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Fennec Pharmaceuticals (FENC) said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.</p><p>Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.</p><p>Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (HZNP), Graceway Pharmaceuticals, and Medicis.</p><p>Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.</p><p>Price: 3.8500, Change: -0.39, Percent Change: -9.20</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1093756325.SGD","symbol_name":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2478102976","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2478102976","pubTimestamp":1730118040,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Fennec Pharmaceuticals  said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon Therapeutics , Graceway Pharmaceuticals, and Medicis.Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.Price: 3.8500, Change: -0.39, Percent Change: -9.20","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4139":"生物科技","HZNP":"Horizon Pharma","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","FENC":"Fennec Pharmaceuticals Inc.","BK4532":"文艺复兴科技持仓","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC"},"translate_title":"Fennec Pharmaceuticals任命首席医疗、商业和战略官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FENC":0.9,"HZNP":0.9},"content_text":"Fennec Pharmaceuticals (FENC) said Monday it has named Pierre S. Sayad as chief medical officer, Terry Evans as chief commercial officer, and Christiana Cioffi as chief strategy officer, starting immediately.Sayad previously served as senior vice president of business development and global medical affairs at the International Myeloma Foundation. In the past, Sayad was a strategic management consultant for Campbell Alliance and served as chief operating officer and interim chief medical officer at Zephyr Labz.Evans previously served as CEO of UNITE Pharma Trade Advisors. Evans also held roles at Currax Pharmaceuticals, Horizon Therapeutics (HZNP), Graceway Pharmaceuticals, and Medicis.Cioffi joined Fennec from Disruptify Consulting where she had served as strategic advisor and leadership coach.Price: 3.8500, Change: -0.39, Percent Change: -9.20","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}